Get Ready for Tims’ China Registration Webcast: Q2 2024 Results Conference Call on Thursday, August 29, 2024!

Welcome to the Tims China Second Quarter Results Blog! Exciting news for coffee lovers in China! SHANGHAI and NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) — TH International Limited (“Tims China” (Nasdaq: THCH)), the exclusive operator of Tim Hortons coffee shops in China, plans to release its second quarter results before market opening on Thursday,…

Read More

IQIYI’s Latest VR Experience in Macao Receives Rave Reviews

IQIYI’s Latest VR Experience in Macao Receives Rave Reviews Expanding Successful VR Adaptations of iQIYI’s Popular IP from ‘Love Between Fairy and Devil’ BEIJING , Aug. 26, 2024 /PRNewswire/ On August 23, iQIYI, China’s leading online entertainment service, announced that its latest VR immersive theater at Galaxy Macau received positive customer feedback following its debut…

Read More

Attention Investors: PDD Holdings Inc. is Calling – Don’t Miss Your Chance to Lead the Case!

Welcome to the World of Securities Litigation Introduction Have you ever found yourself scrolling through your favorite news sites and coming across a headline about a class action lawsuit involving a well-known company and its executives? If so, you’re not alone. Securities litigation is a fascinating and often complex area of law that can have…

Read More

Calling All Investors: Don’t Miss Out on the Five Below Inc. Securities Fraud Class Action Lawsuit!

Legal Troubles: Five Below Faces Securities Class Action Lawsuit What Happened? Recently, the law firm of Kessler Topaz Meltzer & Check, LLP announced that a securities class action lawsuit has been filed against Five Below, Inc. on behalf of investors who purchased or acquired Five Below securities during a specific time frame. The lead plaintiff…

Read More

Unlocking the Power of Accesswire: A Comprehensive Guide to Maximizing Your Online Presence

Levi & Korsinsky Investigation of Syros Pharmaceuticals Investigation Details Levi & Korsinsky has recently announced that it is investigating Syros Pharmaceuticals, Inc. for possible violations of federal securities laws. The investigation stems from a press release issued by Syros on August 12, 2024, in which the company stated that it would be discontinuing enrollment in…

Read More